Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Khouri

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|December 1, 1996
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantationM Körbling, P Anderlini, A Durett, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Bone Marrow Transplantation|June 18, 1999
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemiaD Przepiorka, I Khouri, P Thall, et al.
Blood|December 23, 1999
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host diseaseD Przepiorka, N A Kernan, C Ippoliti, et al.
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|September 11, 2001
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I studyF Ravandi, H Kantarjian, A Cohen, et al.
Bone Marrow Transplantation|March 1, 1997
Allogeneic blood stem cell transplantation in advanced hematologic cancersD Przepiorka, P Anderlini, C Ippoliti, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescueS Giralt, D Weber, M Colome, et al.
Bone Marrow Transplantation|October 21, 2000
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's diseaseP Anderlini, S Giralt, B Andersson, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|December 1, 1996
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantationM Körbling, P Anderlini, A Durett, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Bone Marrow Transplantation|June 18, 1999
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemiaD Przepiorka, I Khouri, P Thall, et al.
Blood|December 23, 1999
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host diseaseD Przepiorka, N A Kernan, C Ippoliti, et al.
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|September 11, 2001
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I studyF Ravandi, H Kantarjian, A Cohen, et al.
Bone Marrow Transplantation|March 1, 1997
Allogeneic blood stem cell transplantation in advanced hematologic cancersD Przepiorka, P Anderlini, C Ippoliti, et al.
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescueS Giralt, D Weber, M Colome, et al.
Bone Marrow Transplantation|October 21, 2000
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's diseaseP Anderlini, S Giralt, B Andersson, et al.
Pageof 8